Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Levetiracetam (LEV) is one of the most widely used anti-seizure medications (ASMs) in clinical practice. This is due both to a different mechanism of action when compared to other ASMs and its easy handling. Indeed, because of its interesting pharmacokinetic properties, it is often used outside of the labeled indications, notably in the neurocritical setting as prophylaxis of epileptic seizures.
Areas Covered: A literature search was conducted and the most relevant studies on the pharmacokinetic properties of LEV were selected by two independent investigators. Current evidence on the use of ASM prophylaxis in the neurocritical setting was also reviewed, highlighting and discussing the strengths and limits of LEV as drug of choice for anti-epileptic prophylaxis in this scenario.
Expert Opinion: LEV has a 'near-ideal' pharmacokinetic profile, which makes it an attractive drug for ASM prophylaxis in neurocritical care. However, current recommendations restrict ASMs prophylaxis to very selected circumstances and the role of LEV is marginal. Moreover, studies are generally designed to compare LEV versus phenytoin, whereas studies comparing LEV versus placebo are lacking. Further, randomized trials will be needed to better elucidate LEV utility and its neuroprotective role in the neurocritical setting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/17425255.2022.2117606 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploratory study on the potential benefits of prophylactic levetiracetam after acute spontaneous intracerebral hemorrhage.
Front Neurol
August 2025
Department of Neurology, Cleveland Clinic Florida/Martin Health, Port Saint Lucie, FL, United States.
Importance: Current guidelines recommend against the routine use of seizure prophylaxis in acute spontaneous intracerebral hemorrhage (sICH).
Objective: The goal of this study is to evaluate if the use of prophylactic levetiracetam resulted in reduced incidence of seizure, morbidity, and length of stay, compared to patients who did not receive prophylactic levetiracetam.
Design: This retrospective chart review includes patients admitted with ICH at Cleveland Clinic Florida Martin Health from January 2019 to October 2022.
Venous thromboembolism prophylaxis practices in hematology/oncology patients admitted to neurological intensive care units.
Front Cardiovasc Med
July 2025
Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Objective: Venous thromboembolism (VTE) presents a significant challenge for neurocritically ill patients with cancer due to the combined risks of thrombosis and bleeding. This study aimed to describe VTE prophylaxis practices among this high-risk population.
Methods: This is a retrospective cohort study at a tertiary teaching hospital.
Acute care of aneurysmal subarachnoid hemorrhage: practical consensus statement from a multidisciplinary group of German-speaking neurointensivists and neuroradiologists on behalf of the DIVI neurology section.
Neurol Res Pract
July 2025
Universitätsklinik für NeurologieEvangelisches Klinikum BethelUniversitätsklinikum OWL, Universität Bielefeld, Bielefeld, Germany.
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is a critical condition requiring multidisciplinary management, particularly in the intensive care setting. Despite existing guidelines, gaps in evidence and variability in practice remain, necessitating practical, consensus-driven recommendations for acute care and management.
Objective: To develop comprehensive, practical consensus statement for the acute management of aSAH, addressing high- and low-evidence areas, through a modified Delphi consensus approach among German-speaking neurointensivists and neuroradiologists.
Influenza-Associated Acute Necrotizing Encephalopathy in US Children.
JAMA
August 2025
Department of Neurology and Pediatric Neuroimmunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Importance: Acute necrotizing encephalopathy (ANE) is a rare, but severe, neurologic condition for which epidemiologic and management data remain limited. During the 2024-2025 US influenza season, clinicians at large pediatric centers anecdotally reported an increased number of children with influenza-associated ANE, prompting this national investigation.
Objective: To understand the clinical presentation, interventions, and outcomes among US children diagnosed with influenza-associated ANE.
Pharmacist's Guide to Common Intracranial Bleeding Terms and Treatments.
Ann Pharmacother
July 2025
Department of Neurosurgery, University of Kentucky College of Medicine, Lexington, KY, USA.
Objective: Pharmacists care for patients with intracranial bleeding such as those with subarachnoid hemorrhage (SAH) or subdural hematoma (SDH), although these bleeding events are often generically termed "head bleed." This over-simplified term refers to a heterogeneous group of life-threatening intracranial hemorrhages, each with a distinctive etiology and treatment paradigm.
Data Sources: Common intracranial hemorrhage types were reviewed to identify the scope of this narrative review.